InsidersTradesSigma
Track the OMADA HEALTH INC stock price and the full management transaction log of the company, a listed equity based in United States. Shares trade on US US, under the authority of SEC (Form 4). Market capitalisation: €1.4bn. The latest transaction was disclosed on 1 July 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: STEVEN L COOK. All data is openly available.
Analysts rate OMADA HEALTH INC Buy (bullish), based on 12 analysts. Average price target: US$23.33.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
7 of 7 declarations
OMADA HEALTH INC is a digital health company that provides chronic disease management programs. It leverages technology to help patients improve their health and prevent diseases.